Myung In Pharmaceutical LTD. (KRX:317450)
South Korea
· Delayed Price · Currency is KRW 72,600
-1,100 (-1.49%)
At close: Dec 5, 2025
KRX:317450 Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2018 |
| Operating Revenue | 283,307 | 269,435 | 242,338 | 225,828 | 209,250 | 187,837 | Upgrade
|
| Other Revenue | - | - | - | -0 | -0 | - | Upgrade
|
| Revenue | 283,307 | 269,435 | 242,338 | 225,828 | 209,250 | 187,837 | Upgrade
|
| Revenue Growth (YoY) | 16.91% | 11.18% | 7.31% | 7.92% | 11.40% | 3.33% | Upgrade
|
| Cost of Revenue | 110,917 | 100,556 | 88,413 | 82,280 | 70,954 | 66,226 | Upgrade
|
| Gross Profit | 172,390 | 168,879 | 153,925 | 143,549 | 138,297 | 121,611 | Upgrade
|
| Selling, General & Admin | 71,576 | 67,800 | 62,249 | 57,227 | 57,643 | 53,001 | Upgrade
|
| Research & Development | 4,762 | 3,684 | 4,037 | 4,749 | 2,448 | 2,651 | Upgrade
|
| Amortization of Goodwill & Intangibles | 1.16 | 1.15 | 0.98 | 1.25 | 1.53 | 1.92 | Upgrade
|
| Other Operating Expenses | 1,650 | 1,588 | 1,485 | 3,564 | 1,326 | 1,236 | Upgrade
|
| Operating Expenses | 81,829 | 76,124 | 70,306 | 67,646 | 64,091 | 56,678 | Upgrade
|
| Operating Income | 90,561 | 92,754 | 83,618 | 75,903 | 74,206 | 64,933 | Upgrade
|
| Interest Expense | -268.22 | -322.65 | -333.54 | -106.64 | -133.33 | -47.92 | Upgrade
|
| Interest & Investment Income | 9,237 | 8,621 | 6,218 | 2,916 | 835.94 | 278.98 | Upgrade
|
| Currency Exchange Gain (Loss) | 1,461 | 5,490 | 1,204 | 2,687 | 4,063 | -2,932 | Upgrade
|
| Other Non Operating Income (Expenses) | 187.07 | -9,548 | 527.79 | 406.58 | 797.02 | 904.06 | Upgrade
|
| EBT Excluding Unusual Items | 101,178 | 96,994 | 91,235 | 81,806 | 79,768 | 63,136 | Upgrade
|
| Gain (Loss) on Sale of Investments | -8,310 | -8,310 | 826.42 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -704.09 | -609.54 | -0.32 | 10.7 | 6.39 | -3,584 | Upgrade
|
| Pretax Income | 92,163 | 88,075 | 92,061 | 81,817 | 79,775 | 59,552 | Upgrade
|
| Income Tax Expense | 19,983 | 19,404 | 17,550 | 24,383 | 20,024 | 14,074 | Upgrade
|
| Net Income | 72,180 | 68,671 | 74,512 | 57,434 | 59,750 | 45,478 | Upgrade
|
| Net Income to Common | 72,180 | 68,671 | 74,512 | 57,434 | 59,750 | 45,478 | Upgrade
|
| Net Income Growth | -3.13% | -7.84% | 29.73% | -3.88% | 31.38% | 6.07% | Upgrade
|
| Shares Outstanding (Basic) | 11 | 11 | 11 | 11 | 11 | 11 | Upgrade
|
| Shares Outstanding (Diluted) | 11 | 11 | 11 | 11 | 11 | 11 | Upgrade
|
| EPS (Basic) | 6407.02 | 6131.31 | 6652.82 | 5128.04 | 5334.82 | 4060.55 | Upgrade
|
| EPS (Diluted) | 6407.02 | 6131.31 | 6652.82 | 5128.04 | 5334.82 | 4060.55 | Upgrade
|
| EPS Growth | -3.69% | -7.84% | 29.73% | -3.88% | 31.38% | 6.07% | Upgrade
|
| Free Cash Flow | 55,651 | 72,783 | 71,428 | 57,643 | 63,407 | 45,488 | Upgrade
|
| Free Cash Flow Per Share | 4939.83 | 6498.51 | 6377.48 | 5146.68 | 5661.37 | 4061.46 | Upgrade
|
| Dividend Per Share | 500.000 | 500.000 | 2000.000 | 1000.000 | 1250.000 | 1750.000 | Upgrade
|
| Dividend Growth | -75.00% | -75.00% | 100.00% | -20.00% | -28.57% | - | Upgrade
|
| Gross Margin | 60.85% | 62.68% | 63.52% | 63.57% | 66.09% | 64.74% | Upgrade
|
| Operating Margin | 31.97% | 34.43% | 34.51% | 33.61% | 35.46% | 34.57% | Upgrade
|
| Profit Margin | 25.48% | 25.49% | 30.75% | 25.43% | 28.55% | 24.21% | Upgrade
|
| Free Cash Flow Margin | 19.64% | 27.01% | 29.47% | 25.52% | 30.30% | 24.22% | Upgrade
|
| EBITDA | 102,816 | 105,217 | 95,058 | 87,238 | 85,824 | 75,894 | Upgrade
|
| EBITDA Margin | 36.29% | 39.05% | 39.23% | 38.63% | 41.02% | 40.40% | Upgrade
|
| D&A For EBITDA | 12,256 | 12,463 | 11,440 | 11,336 | 11,619 | 10,961 | Upgrade
|
| EBIT | 90,561 | 92,754 | 83,618 | 75,903 | 74,206 | 64,933 | Upgrade
|
| EBIT Margin | 31.96% | 34.43% | 34.51% | 33.61% | 35.46% | 34.57% | Upgrade
|
| Effective Tax Rate | 21.68% | 22.03% | 19.06% | 29.80% | 25.10% | 23.63% | Upgrade
|
| Advertising Expenses | - | 31,186 | 27,861 | 25,260 | 27,110 | 24,934 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.